06:37 AM EDT, 07/31/2025 (MT Newswires) -- Biogen (BIIB) reported Q2 non-GAAP earnings Thursday of $5.47 per diluted share, up from $5.28 a year earlier.

Analysts surveyed by FactSet expected $4.03.

Revenue for the quarter ended June 30 was $2.64 billion, up from $2.46 billion a year earlier.

Analysts surveyed by FactSet expected $2.31 billion.

The company said it is increasing its expected full-year 2025 non-GAAP diluted EPS to between $15.50 and $16.00, up from between $14.50 and $15.50 previously.

Analysts surveyed by FactSet expect $15.33.

Biogen shares were up 9.9% in recent premarket activity.